NLRX1/NOD5 deficiency does not affect MAVS signalling
- 27 May 2011
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 18 (8) , 1387
- https://doi.org/10.1038/cdd.2011.64
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- NLRC5 Deficiency Does Not Influence Cytokine Induction by Virus and Bacteria InfectionsThe Journal of Immunology, 2011
- Enhancement of Reactive Oxygen Species Production and Chlamydial Infection by the Mitochondrial Nod-like Family Member NLRX1Journal of Biological Chemistry, 2010
- NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling PathwaysCell, 2010
- The InflammasomesCell, 2010
- An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrixJournal of Cell Science, 2009
- NLRX1 is a mitochondrial NOD‐like receptor that amplifies NF‐κB and JNK pathways by inducing reactive oxygen species productionEMBO Reports, 2008
- NLRX1 is a regulator of mitochondrial antiviral immunityNature, 2008
- The Specific and Essential Role of MAVS in Antiviral Innate Immune ResponsesImmunity, 2006